Study of Tiprogrel in the Treatment of High-risk Patients with Acute Ischemic Cerebrovascular Events (THRIVE).

Abroad (travel likely)RecruitingPHASE2

Conditions

Ischemic Stroke

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Central Hospital Affiliated to Shenyang Medical College, Shenyang, Liaoning, China

    Contact: Study coordinator (Runhui Li) · lirh710717@163.com
  • Beijing Tiantan Hosptial, Capital Medical University, Beijing, China

    Contact: Study coordinator (Yongjun Wang) · yongjunwang@ncrcnd.org.cn